Danazol
- TRADE NAMES: Azol; Bonzol; Cyclomen; D-Zol; Danocrine; Danol; Ladogal; Winobanin; Zoldan-A
- INDICATIONS: Endometriosis, fibrocystic breast disease
- CLASS: Pituitary hormone inhibitor
- HALF-LIFE: ~4.5 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Acenocoumarol, Acitretin, Atorvastatin, Cyclosporine, Insulin Aspart, Insulin Degludec, Insulin Detemir, Insulin Glargine, Insulin Glulisine, Oral Contraceptives, Paricalcitol, Simvastatin, Tacrolimus, Warfarin
PREGNANCY CATEGORY: X
Please login to see the rest of this drug profile
SKIN.
HAIR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric